Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. (Q44961457)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. |
scientific article |
Statements
Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis (English)
Charles H Chesnut
Arne Skag
Claus Christiansen
Robert Recker
Jacob A Stakkestad
Arne Hoiseth
Dieter Felsenberg
Hermann Huss
Ralph C Schimmer
Pierre D Delmas
Oral Ibandronate Osteoporosis Vertebral Fracture Trial in North America and Europe (BONE)
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference